GB2376233B - Crystals of a pharmaceutically acceptable salt of citalopram wherein the median size of the crystals is at least 40 microns - Google Patents

Crystals of a pharmaceutically acceptable salt of citalopram wherein the median size of the crystals is at least 40 microns

Info

Publication number
GB2376233B
GB2376233B GB0219820A GB0219820A GB2376233B GB 2376233 B GB2376233 B GB 2376233B GB 0219820 A GB0219820 A GB 0219820A GB 0219820 A GB0219820 A GB 0219820A GB 2376233 B GB2376233 B GB 2376233B
Authority
GB
United Kingdom
Prior art keywords
crystals
citalopram
microns
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0219820A
Other versions
GB0219820D0 (en
GB2376233A (en
Inventor
Per Holm
Ken Liljegren
Ole Nielsen
Swen Wagner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Original Assignee
H Lundbeck AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck AS filed Critical H Lundbeck AS
Priority claimed from GB0118579A external-priority patent/GB2368014B/en
Publication of GB0219820D0 publication Critical patent/GB0219820D0/en
Publication of GB2376233A publication Critical patent/GB2376233A/en
Application granted granted Critical
Publication of GB2376233B publication Critical patent/GB2376233B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB0219820A 2000-08-10 2001-07-31 Crystals of a pharmaceutically acceptable salt of citalopram wherein the median size of the crystals is at least 40 microns Expired - Fee Related GB2376233B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200001202 2000-08-10
DKPA200001614 2000-10-27
GB0118579A GB2368014B (en) 2000-08-10 2001-07-31 Pharmaceutical composition containing citalopram

Publications (3)

Publication Number Publication Date
GB0219820D0 GB0219820D0 (en) 2002-10-02
GB2376233A GB2376233A (en) 2002-12-11
GB2376233B true GB2376233B (en) 2003-09-10

Family

ID=27222426

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0219820A Expired - Fee Related GB2376233B (en) 2000-08-10 2001-07-31 Crystals of a pharmaceutically acceptable salt of citalopram wherein the median size of the crystals is at least 40 microns

Country Status (1)

Country Link
GB (1) GB2376233B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0171943A1 (en) * 1984-08-06 1986-02-19 H. Lundbeck A/S Novel intermediate and method for its preparation
GB2357762A (en) * 2000-03-13 2001-07-04 Lundbeck & Co As H Preparation of Crystalline Base or Salts of Citalopram
EP1152000A1 (en) * 2000-05-02 2001-11-07 SUMIKA FINE CHEMICALS Co., Ltd. Citalopram hydrobromide crystal and method for crystallization thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0171943A1 (en) * 1984-08-06 1986-02-19 H. Lundbeck A/S Novel intermediate and method for its preparation
GB2357762A (en) * 2000-03-13 2001-07-04 Lundbeck & Co As H Preparation of Crystalline Base or Salts of Citalopram
EP1152000A1 (en) * 2000-05-02 2001-11-07 SUMIKA FINE CHEMICALS Co., Ltd. Citalopram hydrobromide crystal and method for crystallization thereof

Also Published As

Publication number Publication date
GB0219820D0 (en) 2002-10-02
GB2376233A (en) 2002-12-11

Similar Documents

Publication Publication Date Title
NO2020019I1 (en) Maraviroc optionally in the form of a pharmaceutically acceptable salt
GB0117095D0 (en) "Process for the preparation of pure citalopram"
LU91372I2 (en) Retapamulin optionally in the form of a pharmaceutically acceptable salt (altargo)
LU92428I2 (en) Bosutinib, optionally in the form of a pharmaceutically acceptable salt
IL149592A0 (en) Synthesis of 2'-deoxy-l-nucleosides
GB2365865B (en) "Method for the preparation of citalopram"
IL178864A0 (en) 3'-prodrugs of 2'-deoxy-??-l-nucleosides
AU2291001A (en) Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states
EP1136154A4 (en) MANUFACTURE OF A BOTTLE-LIKE CAN
IL146117A0 (en) New pharmaceutically active compounds
PL351261A1 (en) Derivatives of indigoid bisindoles
HUP0202536A3 (en) Crystals of the sodium salt of pravastatin
GB2352173B (en) Amelioration of peyronie's disease
HK1041259A1 (en) Novel crystalline form of the potassium salt of (s)- omeprazole
GB2376233B (en) Crystals of a pharmaceutically acceptable salt of citalopram wherein the median size of the crystals is at least 40 microns
EE200200554A (en) Use of galantamine or a pharmaceutically acceptable salt thereof
AU6769900A (en) Formation of nanometer-scale structures
AU2088000A (en) Surveillance of structures
ITMI991813A0 (en) DEVICE TO RECOGNIZE THE ORIENTATION OF SPOOLS
HUP0201610A3 (en) Derivatives of 4'-demycarosyl-8a-aza-8a-homotylosin
SI1173418T1 (en) Crystalline form 3 of the sodium salt of 5- chloro -2- methoxy -n- (2- (4-methoxy -3- methyl aminothio carbonylamino sulfonylphenyl) ethyl) benzamide
ZA983319B (en) Oscillation of a continuously cast ingot
GB9821967D0 (en) Process for the preparation of orally active cephalosporin antibiotic-cefixim
FR2778564B1 (en) USE OF COMPOUNDS REDUCING APOPTOSIS
HUP0402118A3 (en) Use of propionyl l-carnitine or one of its pharmacologically acceptable salts for the preparation of a medicine for the treatment of la peyronie's disease

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20080731